Northland Capital Markets analyst Gus Richard maintains Luminar Technologies (NASDAQ:LAZR) with a Outperform and lowers the price target from $23 to $13.
In an unusually volatile week, we saw significant market weakness earlier in the week probably driven by forced selling and a relief rally in the end. Insiders once again stepped up their purchases to take advantage of prices, which in some cases are down anywhere from 50% to 90% from their peaks.
Luminar Technologies (NASDAQ:LAZR) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 100 percent decrease over losses of $(0.08) per share
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.